Join us at Cell 2024 at Booth 28 from November 6-8 at the Novotel West in London! We are thrilled to be a network and program sponsor for this event, which will explore the latest advancements in the cell and gene therapy CGT value chain. Stop by to meet our experts and learn about our comprehensive viral vector capabilities. Don’t miss the presentation by Dr. Andre Raposo, Head of Innovation at OXB, titled “Rapid Optimisations for Cell and Gene Therapy Applications” on November 7 at 15:10 in Track 3: Cell Culture & Cell Therapies Quality Control & Analysis. We look forward to seeing you there!
About our presenter, Andre Raposo, PhD
Andre Raposo, PhD, is the Director of Innovation at OXB. He leads a group of scientists delivering cutting-edge research in the field of cell and gene therapy supported by computer-aided biology and high-throughput automation. He has extensive experience in technology development, upstream process development, DoE strategies, analytical development, robotics and associated regulatory compliance. Prior to OXB, Dr. Raposo worked within the Transduction Sciences CGT Platform CMC at GSK. Dr. Raposo holds a PhD from the University of Oxford and specialized in the understanding of host restriction factors controlling HIV replication and the mechanisms leading to HIV persistence and latency during his postdoc at the University of California San Francisco and the George Washington University in the USA.